- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Biological Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Biological Drugs market size is estimated to be worth US$ 291940 million in 2021 and is forecast to a readjusted size of USD 495400 million by 2028 with a CAGR of 7.8% during review period. Hospitals accounting for % of the Biological Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Therapeutic Protein segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Biological Drugs include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, and Amgen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biological Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others
Market segment by Application can be divided into
Hospitals
Ambulatory Surgical Centers
Others
The key market players for global Biological Drugs market are listed below:
Bristol-Myers Squibb
Eli Lilly
Takeda
Pfizer
Amgen
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Abbott Laboratories
Baxter
Novartis
Biogen
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biological Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biological Drugs, with price, sales, revenue and global market share of Biological Drugs from 2019 to 2022.
Chapter 3, the Biological Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Biological Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Drugs.
Chapter 13, 14, and 15, to describe Biological Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Biological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Biological Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Therapeutic Protein
1.2.3 Monoclonal Antibody
1.2.4 Vaccine
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Biological Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Biological Drugs Market Size & Forecast
1.4.1 Global Biological Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Biological Drugs Sales in Volume (2017-2028)
1.4.3 Global Biological Drugs Price (2017-2028)
1.5 Global Biological Drugs Production Capacity Analysis
1.5.1 Global Biological Drugs Total Production Capacity (2017-2028)
1.5.2 Global Biological Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Biological Drugs Market Drivers
1.6.2 Biological Drugs Market Restraints
1.6.3 Biological Drugs Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Biological Drugs Product and Services
2.1.4 Bristol-Myers Squibb Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Biological Drugs Product and Services
2.2.4 Eli Lilly Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business
2.3.3 Takeda Biological Drugs Product and Services
2.3.4 Takeda Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Biological Drugs Product and Services
2.4.4 Pfizer Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Biological Drugs Product and Services
2.5.4 Amgen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 F. Hoffmann-La Roche
2.6.1 F. Hoffmann-La Roche Details
2.6.2 F. Hoffmann-La Roche Major Business
2.6.3 F. Hoffmann-La Roche Biological Drugs Product and Services
2.6.4 F. Hoffmann-La Roche Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Biological Drugs Product and Services
2.7.4 Johnson & Johnson Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Biological Drugs Product and Services
2.8.4 Merck Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business
2.9.3 Abbott Laboratories Biological Drugs Product and Services
2.9.4 Abbott Laboratories Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Baxter
2.10.1 Baxter Details
2.10.2 Baxter Major Business
2.10.3 Baxter Biological Drugs Product and Services
2.10.4 Baxter Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Biological Drugs Product and Services
2.11.4 Novartis Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Biological Drugs Product and Services
2.12.4 Biogen Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 GlaxoSmithKline
2.13.1 GlaxoSmithKline Details
2.13.2 GlaxoSmithKline Major Business
2.13.3 GlaxoSmithKline Biological Drugs Product and Services
2.13.4 GlaxoSmithKline Biological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Biological Drugs Breakdown Data by Manufacturer
3 Biological Drugs Breakdown Data by Manufacturer
3.1 Global Biological Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Biological Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Biological Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Biological Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Biological Drugs Manufacturer Market Share in 2021
3.5 Global Biological Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Biological Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Biological Drugs Market Size by Region
4.1.1 Global Biological Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Biological Drugs Revenue by Region (2017-2028)
4.2 North America Biological Drugs Revenue (2017-2028)
4.3 Europe Biological Drugs Revenue (2017-2028)
4.4 Asia-Pacific Biological Drugs Revenue (2017-2028)
4.5 South America Biological Drugs Revenue (2017-2028)
4.6 Middle East and Africa Biological Drugs Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Biological Drugs Sales in Volume by Type (2017-2028)
5.2 Global Biological Drugs Revenue by Type (2017-2028)
5.3 Global Biological Drugs Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Biological Drugs Sales in Volume by Application (2017-2028)
6.2 Global Biological Drugs Revenue by Application (2017-2028)
6.3 Global Biological Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Biological Drugs Sales by Type (2017-2028)
7.2 North America Biological Drugs Sales by Application (2017-2028)
7.3 North America Biological Drugs Market Size by Country
7.3.1 North America Biological Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Biological Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Biological Drugs Sales by Type (2017-2028)
8.2 Europe Biological Drugs Sales by Application (2017-2028)
8.3 Europe Biological Drugs Market Size by Country
8.3.1 Europe Biological Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Biological Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Biological Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Biological Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Biological Drugs Market Size by Region
9.3.1 Asia-Pacific Biological Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Biological Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Biological Drugs Sales by Type (2017-2028)
10.2 South America Biological Drugs Sales by Application (2017-2028)
10.3 South America Biological Drugs Market Size by Country
10.3.1 South America Biological Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Biological Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Biological Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Biological Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Biological Drugs Market Size by Country
11.3.1 Middle East & Africa Biological Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Biological Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Biological Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Biological Drugs
12.3 Biological Drugs Production Process
12.4 Biological Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Biological Drugs Typical Distributors
13.3 Biological Drugs Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Biological Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Biological Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Biological Drugs Product and Services
Table 6. Bristol-Myers Squibb Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Biological Drugs Product and Services
Table 10. Eli Lilly Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Takeda Basic Information, Manufacturing Base and Competitors
Table 12. Takeda Major Business
Table 13. Takeda Biological Drugs Product and Services
Table 14. Takeda Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Biological Drugs Product and Services
Table 18. Pfizer Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Amgen Basic Information, Manufacturing Base and Competitors
Table 20. Amgen Major Business
Table 21. Amgen Biological Drugs Product and Services
Table 22. Amgen Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 24. F. Hoffmann-La Roche Major Business
Table 25. F. Hoffmann-La Roche Biological Drugs Product and Services
Table 26. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Biological Drugs Product and Services
Table 30. Johnson & Johnson Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Merck Basic Information, Manufacturing Base and Competitors
Table 32. Merck Major Business
Table 33. Merck Biological Drugs Product and Services
Table 34. Merck Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Laboratories Major Business
Table 37. Abbott Laboratories Biological Drugs Product and Services
Table 38. Abbott Laboratories Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Baxter Basic Information, Manufacturing Base and Competitors
Table 40. Baxter Major Business
Table 41. Baxter Biological Drugs Product and Services
Table 42. Baxter Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Novartis Basic Information, Manufacturing Base and Competitors
Table 44. Novartis Major Business
Table 45. Novartis Biological Drugs Product and Services
Table 46. Novartis Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Biogen Basic Information, Manufacturing Base and Competitors
Table 48. Biogen Major Business
Table 49. Biogen Biological Drugs Product and Services
Table 50. Biogen Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 52. GlaxoSmithKline Major Business
Table 53. GlaxoSmithKline Biological Drugs Product and Services
Table 54. GlaxoSmithKline Biological Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Biological Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 56. Global Biological Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Biological Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Biological Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 59. Head Office and Biological Drugs Production Site of Key Manufacturer
Table 60. Biological Drugs New Entrant and Capacity Expansion Plans
Table 61. Biological Drugs Mergers & Acquisitions in the Past Five Years
Table 62. Global Biological Drugs Sales by Region (2017-2022) & (K MT)
Table 63. Global Biological Drugs Sales by Region (2023-2028) & (K MT)
Table 64. Global Biological Drugs Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Biological Drugs Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 67. Global Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 68. Global Biological Drugs Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Biological Drugs Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Biological Drugs Price by Type (2017-2022) & (USD/MT)
Table 71. Global Biological Drugs Price by Type (2023-2028) & (USD/MT)
Table 72. Global Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 73. Global Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 74. Global Biological Drugs Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Biological Drugs Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Biological Drugs Price by Application (2017-2022) & (USD/MT)
Table 77. Global Biological Drugs Price by Application (2023-2028) & (USD/MT)
Table 78. North America Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 79. North America Biological Drugs Sales by Country (2023-2028) & (K MT)
Table 80. North America Biological Drugs Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Biological Drugs Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 83. North America Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 84. North America Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 85. North America Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 86. Europe Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 87. Europe Biological Drugs Sales by Country (2023-2028) & (K MT)
Table 88. Europe Biological Drugs Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Biological Drugs Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 91. Europe Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 92. Europe Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 93. Europe Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 94. Asia-Pacific Biological Drugs Sales by Region (2017-2022) & (K MT)
Table 95. Asia-Pacific Biological Drugs Sales by Region (2023-2028) & (K MT)
Table 96. Asia-Pacific Biological Drugs Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Biological Drugs Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 99. Asia-Pacific Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 100. Asia-Pacific Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 101. Asia-Pacific Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 102. South America Biological Drugs Sales by Country (2017-2022) & (K MT)
Table 103. South America Biological Drugs Sales by Country (2023-2028) & (K MT)
Table 104. South America Biological Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Biological Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 107. South America Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 108. South America Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 109. South America Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 110. Middle East & Africa Biological Drugs Sales by Region (2017-2022) & (K MT)
Table 111. Middle East & Africa Biological Drugs Sales by Region (2023-2028) & (K MT)
Table 112. Middle East & Africa Biological Drugs Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Biological Drugs Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Biological Drugs Sales by Type (2017-2022) & (K MT)
Table 115. Middle East & Africa Biological Drugs Sales by Type (2023-2028) & (K MT)
Table 116. Middle East & Africa Biological Drugs Sales by Application (2017-2022) & (K MT)
Table 117. Middle East & Africa Biological Drugs Sales by Application (2023-2028) & (K MT)
Table 118. Biological Drugs Raw Material
Table 119. Key Manufacturers of Biological Drugs Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Biological Drugs Typical Distributors
Table 123. Biological Drugs Typical Customers
List of Figures
Figure 1. Biological Drugs Picture
Figure 2. Global Biological Drugs Revenue Market Share by Type in 2021
Figure 3. Therapeutic Protein
Figure 4. Monoclonal Antibody
Figure 5. Vaccine
Figure 6. Others
Figure 7. Global Biological Drugs Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Others
Figure 11. Global Biological Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Biological Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Biological Drugs Sales (2017-2028) & (K MT)
Figure 14. Global Biological Drugs Price (2017-2028) & (USD/MT)
Figure 15. Global Biological Drugs Production Capacity (2017-2028) & (K MT)
Figure 16. Global Biological Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Biological Drugs Market Drivers
Figure 18. Biological Drugs Market Restraints
Figure 19. Biological Drugs Market Trends
Figure 20. Global Biological Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Biological Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Biological Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Biological Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Biological Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Biological Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Biological Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Biological Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Biological Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Biological Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Biological Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Biological Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Biological Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Biological Drugs Price by Type (2017-2028) & (USD/MT)
Figure 35. Global Biological Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Biological Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Biological Drugs Price by Application (2017-2028) & (USD/MT)
Figure 38. North America Biological Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Biological Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Biological Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Biological Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Biological Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Biological Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Biological Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Biological Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Biological Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Biological Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Biological Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Biological Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Biological Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Biological Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Biological Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Biological Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Biological Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Biological Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Biological Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Biological Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Biological Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Biological Drugs in 2021
Figure 79. Manufacturing Process Analysis of Biological Drugs
Figure 80. Biological Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
